Concepedia

Publication | Closed Access

Real‐World Effectiveness of Initial Disease‐Modifying Therapies in Pediatric <scp>Multiple Sclerosis</scp>

DOI

107

Citations

36

References

2020

Year

Kristen M. Krysko, Jennifer Graves, Mary Rensel, Bianca Weinstock‐Guttman, Alice Rutatangwa, Gregory Aaen, Anita Belman, Leslie Benson, Tanuja Chitnis, Mark Gorman,
Annals of Neurology

Abstract

Initial treatment of pediatric MS/CIS with newer DMTs led to better disease activity control compared to injectables, supporting greater effectiveness of newer therapies. Long-term safety data for newer DMTs are required. ANN NEUROL 2020 ANN NEUROL 2020;88:42-55.

References

YearCitations

Page 1